|
| Press Releases |
|
 |
|
| Friday, August 16, 2024 |
|
|
China Medical System (00867) Released its 2024 Interim Results: Steady Increase in Revenue and Profit Compared with 2H 2023 |
| On August 15, 2024, China Medical System Holdings Limited ("CMS" or the "Company") released its 2024 interim results announcement, with a steady increase in overall revenue and profit for the period compared to the second half (2H) of 2023. In the first half (1H) of 2024, the Company recorded a turnover of RMB3,611.1 million, representing a decrease of 21.7% compared with 1H 2023, an increase of 6.1% compared with 2H 2023. more info >> |
|
| Monday, August 5, 2024 |
|
|
China Medical System: NDA for Additional Rheumatoid Arthritis Indication of Methotrexate Injection Approved in China |
| China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 30 July 2024, the New Drug Application (NDA) for an additional indication of Methotrexate Injection (the "Product") has been approved by the National Medical Products Administration of China (NMPA). more info >> |
|
| Tuesday, July 16, 2024 |
|
|
China Medical System (867.HK) Reincluded in S&P Global Sustainability Yearbook (China Edition) and Maintained MSCI ESG "AA" Rating |
| In July 2024, China Medical System Holdings Limited ("CMS" or the "Group") has once again been recognized for its outstanding performance and continuous progress in sustainable development. more info >> |
|
| Tuesday, June 25, 2024 |
|
|
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China |
| On June 25, China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") announced the completion of dosing for the first subject in the phase III bridging trial of ruxolitinib cream (the "Product") in atopic dermatitis ("AD") in China. more info >> |
|
| Tuesday, June 18, 2024 |
|
|
China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China |
| more info >> |
|
| Tuesday, April 23, 2024 |
|
|
China Medical System: New Drug Application of Desidustat Tablets Accepted in China |
| China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that on 22 April 2024, the New Drug Application (NDA) of Desidustat Tablets ("Desidustat Tablets" or the "Product") has been accepted by the National Medical Products Administration of China (NMPA). more info >> |
|
| Monday, April 1, 2024 |
|
|
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia |
| more info >> |
|
| Thursday, March 28, 2024 |
|
|
China Medical System (867.HK) 2023 Annual Results: Despite of the Temporary Financial Performance Pressure, Fresh Catalysts Emerged from Successive Innovation Breakthroughs |
| more info >> |
|
| Sunday, February 4, 2024 |
|
|
China Medical System (00867) Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro(R) |
| more info >> |
|
| Tuesday, January 2, 2024 |
|
|
CMS(00867) Joins Hands with Pharmaron to Promote the Singapore Manufacturing Plant Acquisition and CDMO Business in SEA |
| more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
U.S. Polo Assn. Celebrates Sport and Style as Official Apparel Sponsor of the 2025 Engel & Volkers Berlin Maifeld Polo Cup
Sept 16, 2025 19:00 HKT/SGT
|
|
|
MIHAS 2025, World's Largest Halal Exhibition Opens Tomorrow
Sept 16, 2025 14:47 HKT/SGT
|
|
|
Honda Develops New "Chemical Sorting" Technology to Separate Solid Contaminants from Waste Plastics Derived from End-of-life Automobiles
Sept 16, 2025 15:00 JST
|
|
|
Champion REIT Awarded Hang Seng ESG 'AA+' Top-Tier Rating and Included in Benchmark Index 
Sept 16, 2025 13:08 HKT/SGT
|
|
|
NEC Publishes ESG Initiatives Supporting Sustainable Growth of Companies and Society in "ESG Databook 2025"
Sept 16, 2025 14:00 JST
|
|
|
Trading Central Launches FIBI: AI-Powered Financial Assistant Live Across Research Tools
Sept 16, 2025 09:15 HKT/SGT
|
|
|
How Not to Lose the Billion Dollars You Didn't Know You Had - Groundbreaking Guide to Protecting Family Fortunes
Sept 16, 2025 08:30 HKT/SGT
|
|
|
JSR Corporation/Inpria Corporation and Lam Research Enter Cross Licensing and Collaboration Agreement to Advance Semiconductor Manufacturing
Sept 16, 2025 9:00 JST
|
|
|
GMG Announces Graphene Coating Patent Approval and Customer Case Study Successes
Sept 15, 2025 20:09 HKT/SGT
|
|
|
CTF Life+ Initiative Strengthens Company Connections with the Younger Generation
Sept 15, 2025 17:33 HKT/SGT
|
|
|
Focus Graphite and C4V Report Breakthrough Early Results Showing 26% Improvement in LFP Cathode Density Using Lac Knife Cathode Ultima
Sept 15, 2025 17:09 HKT/SGT
|
|
|
HKTDC releases research report on biomedicine, Industry development drives GBA global tech leadership
Sept 15, 2025 15:19 HKT/SGT
|
|
|
Toyota Launches Next-Generation New Mobility e-Palette
Sept 15, 2025 15:33 JST
|
|
|
Announcing the results of the 42nd Hong Kong Watch and Clock Design Competition
Sept 15, 2025 11:27 HKT/SGT
|
|
|
Submarine Networks World 2025 - the annual flagship event for the global subsea industry returns to Singapore in September.
Sept 15, 2025 08:00 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
